nstitute of Health and Consumer Protection for the European Commission's Joint Research Centre, where the European Centre for the Validation of Alternative Methods, ICCVAM's European counterpart, is located. Anklam has signed the agreement as representative on behalf of the EU. Her colleague Joachim Kreysa, Ph.D., the recently appointed head of ECVAM, further remarked, "I am enthusiastic about the agreement. Our collaboration will help to identify and embrace scientifically sound and robust new testing approaches, ensuring that safety assessments are never compromised, while at the same time reduce the need for animal testing."
"Although we've had informal collaborations over the years, this more formal agreement will allow us to work more efficiently and effectively," said Hajime Kojima, Ph.D., director of the Japanese Centre for the Validation of Alternative Methods.
David Blakey, D.Phil., director of the Environmental Health Science and Research Bureau within Health Canada, added that the effort is a major step forward. "Increased coordination, collaboration and communication will clearly enhance the global progress in this important area."
'/>"/>
Page: 1 2 3 Related biology news :1.
HPV DNA test identifies cervical pre-cancerous disease in developing countries with 90% success rate2.
Early cessation of breastfeeding by HIV+ women in poor countries and child survival3.
Fertility treatment in developing countries; a cycle of IVF for less than $2004.
Extreme nausea and vomiting varies among pregnant women from different countries5.
Conservation of freshwater fish biodiversity: a challenge for the countries of the South6.
Sanitation investment in poor countries would yield $9-to-1 benefits in productivity, health: UN7.
New way to produce high-vitamin corn could improve nutrition in developing countries8.
Sweet potato shines as new promise for small enterprise and hunger relief in developing countries9.
Hand hygiene initiative aims to decrease healthcare-associated infection in developing countries10.
Data on life expectancy show many countries clustered in high mortality traps11.
M2SYS Partners With Gnosis Medical Services to Provide Accurate Patient Identification in Developing Countries Through Innovative Biometrics Solution